Charles McDermott

Charles McDermott

Sep 18, 2018

Charles (Charlie) McDermott has more than 25 years of experience in the life sciences industry and has held roles of increasing responsibility in drug discovery, regulatory affairs, corporate development, commercial planning, and executive management. Most recently...
James Appleman, PhD

James Appleman, PhD

Dec 27, 2017

James (Jim) Appleman, Ph.D., is Chief Scientific Officer, Senior Vice President of R&D, and a cofounder of Primmune Therapeutics. He has more than 30 years of experience in building successful drug discovery organizations and has been an advisor to biotech,...
Paulo Rangel

Paulo Rangel

Dec 27, 2017

Paulo Rangel is the Chief Business Officer and cofounder of Primmune and brings 25 years of experience in the pharmaceutical and related industries in both small and large companies. Before Primmune, Mr. Rangel was President, CEO, and cofounder of Evince Biosciences,...
Curtis Scribner, MD

Curtis Scribner, MD

Jul 14, 2021

Curtis Scribner, M.D., is a board-certified internal medicine specialist with extensive experience in drug development as a clinical investigator, regulatory reviewer, and strategic product life cycle consultant. Dr. Scribner spent 10 years at the FDA’s Center for...
Marc Veale

Marc Veale

Jul 22, 2024

Marc Veale has more than 25 years of finance and accounting experience in the life science industry and has held roles of increasing responsibility in companies that span from development stage biotechnology start-ups to large, publicly held global commercial...